Related Experiment Video

Updated: Jun 24, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts

Leonardo Pantoni1, Anna Poggesi, Domenico Inzitari

  • 1Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy. pantoni@unifi.it

Cerebrovascular Diseases (Basel, Switzerland)
|April 4, 2009
PubMed

Insights

Cerebrovascular diseases (CVDs) significantly contribute to cognitive decline in the elderly, often interacting with Alzheimer's-type neurodegeneration. Recognizing CVDs is crucial for understanding and managing cognitive impairment and loss of independence.

Area of Science:

  • Neurology
  • Geriatrics
  • Epidemiology

Background:

  • Cerebrovascular diseases (CVDs) are the second leading cause of cognitive decline in older adults, following Alzheimer's disease.
  • The full impact of CVDs on cognitive decline is underestimated by healthcare professionals and regulators.

Purpose of the Study:

  • To review evidence on the clinical relevance of CVDs in cognitive decline.
  • To present key concepts for recognizing the problem of CVDs and cognitive impairment.

Main Methods:

  • Position paper reviewing existing evidence.
  • Discussion of clinical, neuroimaging, and pathological approaches.
  • Identification of crucial concepts for problem recognition.

Main Results:

  • Inconsistent approaches and definitions hinder the appreciation of CVDs' role in cognitive decline.
  • Cognitive impairment due to CVDs is frequent, heterogeneous, and has significant epidemiological impact.
  • Vascular lesions, particularly white matter lesions and lacunar infarcts, are strong determinants of cognitive decline, often interacting with Alzheimer's pathology.

Conclusions:

  • Standardized definitions and integrated approaches are needed to fully appreciate CVDs' contribution to cognitive decline.
  • Cognitive impairment from CVDs is a major public health issue with diverse clinical and pathogenic presentations.
  • CVDs lead to a broader range of functional impairments, including gait disturbances, depression, and incontinence, contributing to loss of independence.
Abstract

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...